You are about to leave the Clinical Value website now.


APASL 2023 Taiwan Congress Report

You May Also Like

APASL 2023 Taiwan Symposium

Watch the APASL 2023 symposium recording to hear experts share key updates on HCC surveillance, diagnosis, uHCC management and adj HCC systemic treatment.

Read More
12 April 2023

PIVKA-II: Confidence in HCC surveillance and diagnosis: Prof. Ming-Lung Yu

In this video, Prof Ming-Lung Yu, Chair Professor of Hepatology at Kaohsiung University Medical Hospital, discusses how PIVKA-II can complement AFP and Ultrasound in assisting clinicians in the early detection…

Read More
17 March 2023

Utility of Combining PIVKA-II and AFP in the Surveillance and Monitoring of Hepatocellular Carcinoma in the Asia-Pacific Region

A panel of 17 experts from Asia-Pacific, gathered to discuss and reach a consensus on the clinical usefulness and value of PIVKA-II for the surveillance and treatment monitoring of HCC,…

Read More


Be the first to receive updates, event opportunities, and thought leadership insights.